US EditionPublished • loading... • Updated
A drug currently being tested in clinical trials for a rare blood cancer could also be used to treat lobular breast cancer.
Summary by radiojackie.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
A drug currently being tested in clinical trials for a rare blood cancer could also be used to treat lobular breast cancer.
Scientists at The Institute of Cancer Research in Sutton have found the LOX inhibitor can slow its growth and spread in mice. Lobular makes up about 15% of all breast cancers, beginning in the milk producing-glands known as lobules. The researchers now hope to progress the drug to clinical trials.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
